This inventor holds 35 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents, primarily in Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Dyncorp. Active years: 1976-2022.
Location History:
- Betheseda, MD (US) (2009 - 2012)
- Bethesda, MD (US) (1976 - 2022)
Company Filing History:
19 out of 3,688 
6 out of 1,217 
4 out of 7 
Years Active: 1976-2022
Areas of Expertise:
Title: Innovations and Contributions of Robert M. Chanock in Vaccine Development
Introduction
Robert M. Chanock, located in Bethesda, Maryland, is a prominent inventor known for his significant contributions to the field of virology and vaccine development. With an impressive portfolio of 35 patents, he has played a vital role in enhancing public health through innovative medical solutions.
Latest Patents
Among his latest groundbreaking patents is the construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine aimed at preventing diseases caused by the West Nile virus. This invention relates to attenuated, immunogenic West Nile virus chimeras that are built on a dengue virus backbone, paving the way for the production of effective, live, attenuated West Nile virus vaccines.
Career Highlights
Throughout his illustrious career, Chanock has made significant strides in the development of vaccines against various infectious diseases. He has worked with esteemed organizations such as the United States of America, represented by the Department of Health and Human Services, and the Department of Health. These collaborations have facilitated the advancement of his innovative research.
Collaborations
Robert M. Chanock has collaborated with notable coworkers such as Brian R. Murphy and Albert Z. Kapikian. These partnerships have been instrumental in furthering his research and bringing impactful inventions to fruition.
Conclusion
Robert M. Chanock's contributions to the field of infectious disease prevention through innovative vaccines exemplify the spirit of scientific advancement. His extensive patent portfolio and collaborations with prestigious institutions underscore his commitment to improving global health outcomes through pioneering solutions.